Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01221506 | Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC) | completed | Early Phase 1 | 20 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT04321161 | Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment | completed | Early Phase 1 | 10 | University of FreiburgOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT03592121 |
| Study to Investigate the Effect of AB-101 in Breast Cancer Survivors |
| completed |
| Early Phase 1 |
| 3 |
| Applied Biology, Inc.INDUSTRY |
| 1 |
| Mar 12, 2020 |
| clinicaltrials |
| NCT00331630 | Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | completed | Early Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT04289532 | Integrin α6-targeted SPECT Imaging of Breast Cancer | completed | Early Phase 1 | 9 | Peking UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT01670799 | Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer | completed | Early Phase 1 | 29 | New Mexico Cancer Research AllianceOTHER | 1 | Feb 27, 2020 | clinicaltrials |
| NCT01380353 | Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine | completed | Early Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT01705288 | Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study | completed | Early Phase 1 | 103 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT02604862 | Imaging FIB ONE in the Human Lung Using Endomicroscopy(FIB ONE) | completed | Early Phase 1 | 18 | University of EdinburghOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT04145323 | Novel Application of Indocyanine Green as a Biomarker to Identify Tissue Necrosis in Mastectomy Patients | completed | Early Phase 1 | 10 | University of Wisconsin, MadisonOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT01239875 | Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma | completed | Early Phase 1 | 16 | Mayo ClinicOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT02320305 | MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery | completed | Early Phase 1 | 23 | Mayo ClinicOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT00013533 | Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies | completed | Early Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT01894451 | Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy | completed | Early Phase 1 | 2 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01263613 | Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer | completed | Early Phase 1 | 6 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT01753908 | Broccoli Sprout Extract in Treating Patients With Breast Cancer | completed | Early Phase 1 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Oct 31, 2019 | clinicaltrials |
| NCT02316795 | Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | completed | Early Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT04056026 | A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma | completed | Early Phase 1 | 1 | ProgenaBiomeOTHER | 1 | Sep 23, 2019 | clinicaltrials |
| NCT01730729 | Cabergoline in Metastatic Breast Cancer | completed | Early Phase 1 | 20 | Northwestern UniversityOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT02628080 | Atovaquone as Tumour HypOxia Modifier(ATOM) | completed | Early Phase 1 | 46 | University of OxfordOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT04017845 | Screening for Colorectal Cancer in Average and High Risk Population | completed | Early Phase 1 | 537 | Lewai Sharki Abdulaziz, MSc PhDOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT00795457 | Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas | completed | Early Phase 1 | 13 | Ian F. Pollack, M.D.OTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT01504126 | Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Early Phase 1 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 29, 2019 | clinicaltrials |
| NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT(GCC 1324) | completed | Early Phase 1 | 8 | University of Maryland, BaltimoreOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT01722149 | Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma | completed | Early Phase 1 | 4 | University of ZurichOTHER | 1 | Aug 7, 2019 | clinicaltrials |
| NCT04046016 | A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor | completed | Early Phase 1 | 2 | Seoul National University HospitalOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT01789827 | Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy | completed | Early Phase 1 | 5 | Mayo ClinicOTHER | 1 | Aug 5, 2019 | clinicaltrials |
| NCT01747798 | Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Early Phase 1 | 10 | Mayo ClinicOTHER | 1 | Aug 2, 2019 | clinicaltrials |
| NCT02806817 | ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism | completed | Early Phase 1 | 40 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT00214422 | Intensity Modulated Radiation Therapy for Prostate Cancer | completed | Early Phase 1 | 19 | National Cancer Institute (NCI)NIH | 1 | Jul 19, 2019 | clinicaltrials |
| NCT03315065 | 19F Thoracic Radiotherapy for Lung Cancer | completed | Early Phase 1 | 6 | Hal C CharlesOTHER | 1 | Jul 16, 2019 | clinicaltrials |
| NCT01660529 | Multi-peptide Vaccine With Basilixumab for Breast Cancer | completed | Early Phase 1 | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT02295956 | Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer | completed | Early Phase 1 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT02729194 | Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma | completed | Early Phase 1 | 16 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 10, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT02285738 | Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | completed | Early Phase 1 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT02190279 | 18F-DCFBC PET/CT in Prostate Cancer | completed | Early Phase 1 | 116 | National Cancer Institute (NCI)NIH | 1 | Apr 23, 2019 | clinicaltrials |
| NCT03923998 | Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers | completed | Early Phase 1 | 8 | Indrayani Hospital and Cancer InstituteOTHER | 1 | Apr 23, 2019 | clinicaltrials |
| NCT01594242 | Autophagy Induction After Bortezomib for Myeloma | completed | Early Phase 1 | 11 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT02735356 | Topical Itraconazole in Treating Patients With Basal Cell Cancer | completed | Early Phase 1 | 9 | Jean Yuh TangOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT00908791 | Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | completed | Early Phase 1 | 24 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 1, 2019 | clinicaltrials |
| NCT02768389 | Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma | completed | Early Phase 1 | 18 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 15, 2019 | clinicaltrials |
| NCT01286675 | Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT | completed | Early Phase 1 | 19 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT01666353 | PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy | completed | Early Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 8, 2019 | clinicaltrials |
| NCT02463994 | A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC | completed | Early Phase 1 | 12 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 8, 2019 | clinicaltrials |
| NCT02847000 | p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer | completed | Early Phase 1 | 13 | Yogen SaunthararajahOTHER | 1 | Jan 9, 2019 | clinicaltrials |
| NCT02846935 | p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies | completed | Early Phase 1 | 7 | Yogen SaunthararajahOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT02836288 | Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer | completed | Early Phase 1 | 4 | Scott A. Irwin, MD, PhDOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT00640861 | Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer | completed | Early Phase 1 | 45 | Mayo ClinicOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00662233 | Combination Chemotherapy in Treating Patients With Sarcoma | completed | Early Phase 1 | 28 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Mar 26, 2020source: clinicaltrials